SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 1, 2026

BLLN

BillionToOne, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $610K total
Actionable Insight • Neutral

The insider sales are small relative to market cap and likely liquidity-driven. The lease expansion signals management confidence in volume growth. Monitor for any follow-on insider buying or further 8-K filings on the build-out timeline.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
BLLN ▲ +1.14% at T+60d
NEUTRAL call +1.14% · α vs SPY -1.91% · entry $120.35 → $121.72
Entry = T+0 close
Jul 1, 2026
via day close
T+1d
+2.53%
call +2.53% · α +1.66%
$123.40
settled 4mo ago
T+5d
+5.33%
call +5.33% · α +3.97%
$126.77
settled 4mo ago
T+20d
+15.16%
call +15.16% · α +14.86%
$138.60
settled 3mo ago
T+60d
+1.14%
call +1.14% · α -1.91%
$121.72
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Two insiders at BillionToOne sold a combined $610K in stock over the past week, including the SVP of Laboratory Operations and the Chief Product Officer. The sales occurred just after the company announced a $46.7M lease expansion to triple oncology lab capacity, suggesting the sales are likely liquidity-driven (vesting/10b5-1) rather than a bearish signal on the business. The dollar value is ~0.01% of market cap, well below the materiality threshold.

Key Financial Metrics

Direction
selling
Total Value
$610.0K
Insiders
2

Key Facts

  • Two insiders sold a combined $610K in open-market transactions over a 7-day window.
  • SVP of Laboratory Operations sold 1,416 shares at $120 for $170K on June 29.
  • Chief Product Officer sold 4,000 shares at $110 for $440K on June 24.
  • Total sales represent ~0.01% of BLLN's $5.6B market cap — well below the materiality threshold.
  • The sales follow a June 23 lease agreement for 62,659 sq ft of lab space with $46.7M in total rent, tripling oncology lab capacity.

Financial Impact

Total insider sales of $610K represent ~0.01% of BLLN's $5.6B market cap — immaterial.

insider holdings

Risk Factors

  • Insider sales could accelerate if the stock continues to appreciate post-lease announcement.
  • Lease build-out costs could pressure near-term cash flow.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BLLN-1782978229244
29 reports for BLLN
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 9 of 9 best @ T+60▲ +26.26%Mar 4, 2026
Filters
Rows
Reports for BLLN — sortable, filterable
TypeNow
Sep 30, 2026
26d ago
Insider Cluster
BEARISH ★ 5/10
$105.76awaiting T+60—$114.07 (−7.86%)
Sep 28, 2026
29d ago
Insider Cluster
BEARISH ★ 5/10
$118.18awaiting T+60—$114.07 (+3.48%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$124.90awaiting T+60—$114.07 (+8.67%)
Sep 22, 2026
5w ago
Institutional Cluster
BULLISH ★ 4/10
$116.07awaiting T+60—$114.07 (−1.72%)
Sep 21, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$116.07awaiting T+60—$114.07 (+1.72%)
Sep 16, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$110.67awaiting T+60—$114.07 (−3.07%)
Sep 11, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$100.82awaiting T+60—$114.07 (+13.14%)
Sep 11, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$100.82awaiting T+60—$114.07 (+13.14%)
Aug 27, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$93.24awaiting T+60—$114.07 (+22.34%)
Aug 27, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$93.24awaiting T+60—$114.07 (+22.34%)
Showing 10 of 29

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026